Quantitative Real Time PCR instrument

The European Commission's Joint Research Centre (JRC) is preparing to issue a procurement opportunity for a Quantitative Real-Time PCR instrument aimed at enhancing laboratory capabilities. This initiative focuses on replacing an outdated PCR instrument that is no longer functional and cannot be repaired. The new equipment is critical for DNA and RNA analyses related to environmental samples, specifically in projects addressing antimicrobial resistance and monitoring drinking and bathing water quality.

Eligible applicants for this procurement are likely suppliers of laboratory equipment, but exact eligibility types, including whether SMEs are encouraged, are not clearly defined. The funding type is categorized as a procurement contract rather than a grant. No consortium is required, allowing a single applicant to fulfill the contract.

Geographic eligibility generally follows EU procurement standards, likely open to companies within the EU and partners in associated countries. The project itself is in the commercialization stage, intending to acquire a ready-to-use instrument.

The estimated funding amount is not specified, but it falls within a middle or low value procurement contract. Interested parties must submit their expressions of interest electronically, starting June 23, 2025, and ending on July 5, 2025. The indicative launch date for the negotiated procedure is set for July 7, 2025.

The opportunity signifies the procurement of supplies with a maximum contract duration of three months. This notification serves as a preliminary alert for potential bidders to prepare for the upcoming formal tender invitation.

This is a publication announcing the European Commission, DG JRC Joint Research Centre's intention to publish a future negotiated low or middle value procedure. It is not a call for tenders. The procedure identifier is EC-JRC/IPR/2025/LVP/3290-EXA. The subject of the planned call for tenders is a Quantitative real-time PCR instrument for DNA and RNA analyses of environmental samples. This instrument is intended to replace the existing real-time PCR instrument 7900 HT in the laboratories, which is no longer functional and cannot be repaired. The instrument is routinely used in experiments related to Antimicrobial Resistance, drinking and bathing water projects. The procedure type is a planned negotiated procedure for a middle/low value contract. The nature of the contract is for supplies. The maximum contract duration is 3 months. No framework agreement is mentioned. The start date for expression of interest is 2025-06-23 Europe/Brussels. The deadline for expression of interest is 05/07/2025 04:59 Europe/Rome. The indicative date of launch of the negotiated procedure is 2025-07-07 Europe/Rome. The method of expression of interest is electronic, and interested parties can express their interest via the provided link. The main classification (CPV) code is 38000000 Laboratory, optical and precision equipments (excl. glasses). Submissions must be sent exclusively at the address for submission given.

The European Commission, specifically the DG JRC Joint Research Centre, is planning to launch a negotiated procurement procedure for a low to middle value contract. The purpose of this procurement is to acquire a new quantitative real-time PCR instrument. This instrument will be used for DNA and RNA analysis of environmental samples and will replace an older, non-repairable instrument currently used in the JRC laboratories. The new instrument will support research projects focused on antimicrobial resistance, as well as the analysis of drinking and bathing water quality. The contract will be for supplies, with a maximum duration of three months. Companies interested in participating in this future tender are invited to express their interest electronically. The expression of interest period begins on June 23, 2025, and ends on July 5, 2025. The contracting authority anticipates launching the negotiated procedure around July 7, 2025. This announcement serves as an advance notice, allowing potential bidders to prepare for the upcoming opportunity.

Eligible Applicant Types: The opportunity is a planned negotiated procedure for a middle/low value contract, suggesting that eligible applicants are likely to be suppliers of laboratory equipment, specifically those capable of providing a quantitative real-time PCR instrument. The exact types of eligible applicants (SME, large enterprise, etc.) are not explicitly stated, but it is implied that they are businesses involved in the supply of relevant equipment.

Funding Type: This is a procurement opportunity, specifically a planned negotiated procedure for a supply contract. The funding type is therefore procurement.

Consortium Requirement: The information does not explicitly state whether a single applicant or a consortium is required. However, given the nature of the procurement for a specific instrument, it is more likely that single applicants (individual companies) are expected to bid.

Beneficiary Scope (Geographic Eligibility): The opportunity is published by the European Commission, DG JRC, suggesting that the geographic eligibility is likely within the EU or countries that have agreements with the EU regarding procurement. The exact geographic eligibility is not explicitly stated in the provided text, but it is reasonable to assume it includes at least EU member states.

Target Sector: The target sector is laboratory equipment supply, specifically for quantitative real-time PCR instruments. This falls under the broader categories of biotech/medtech, pharma/healthcare, and potentially environmental science due to the instrument's use in analyzing environmental samples.

Mentioned Countries: No specific countries are mentioned. The contracting authority is the European Commission, DG JRC, implying that the opportunity is relevant to the EU.

Project Stage: This opportunity concerns the supply of a ready-made instrument, so the relevant stage is commercialization. The JRC is looking to purchase an existing product to replace an older, non-functional instrument.

Funding Amount: The opportunity is described as a "low or middle value procedure," but the estimated total value is not explicitly stated. Therefore, the funding range is variable, but it is likely to be in the range considered low to middle value for EU procurement contracts.

Application Type: The application type is a planned negotiated procedure. This means that the contracting authority will likely invite specific suppliers to submit bids after an initial expression of interest.

Nature of Support: The beneficiaries (suppliers) will receive money in exchange for supplying the quantitative real-time PCR instrument. The nature of support is therefore monetary.

Application Stages: Based on the information provided, there are at least two stages: an expression of interest and a subsequent negotiated procedure where selected suppliers will be invited to submit bids. Therefore, there are at least 2 stages.

Success Rates: The success rates are not mentioned. As this is a negotiated procedure, the success rate for those invited to bid will likely be higher than an open call, but this is speculative. The success rate is other.

Co-funding Requirement: Co-funding is not mentioned, and it is unlikely to be required for a procurement contract of this nature. The answer is no.

Summary:

This opportunity is a pre-announcement by the European Commission's Joint Research Centre (JRC) regarding a future procurement procedure. The JRC intends to purchase a quantitative real-time PCR instrument to replace an outdated model in its laboratories. This instrument is crucial for DNA and RNA analyses of environmental samples, particularly in projects related to antimicrobial resistance and water quality.

The procedure will be a negotiated procedure for a low or middle value contract. The first step is an expression of interest, with a deadline of July 5, 2025. The indicative date for launching the negotiated procedure is July 7, 2025. Interested suppliers of laboratory equipment, specifically quantitative real-time PCR instruments, should monitor the EU Funding & Tenders Portal for the official call and instructions on how to express their interest. This is not a call for tenders yet, but a notification of a future opportunity. The contract duration is a maximum of 3 months.